Jeffrey R Fineman
Biographic Data
| ID | 8252280 |
|---|---|
| NAME | Jeffrey R Fineman |
| GIVEN NAMES | Jeffrey R |
| FAMILY NAME | Fineman |
| SIGNATURE | FINEMAN J R |
| AFFILIATIONS | University of California, San Francisco |
| ORCID | 0000-0001-9740-405X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibility, safety, and neuroprotective efficacy of clemastine administration in near-term lambs ( n = 25, 141-143 days) following a global ischemic insult i…
Progress in Pulmonary Vein Stenosis
Pulmonary vein stenosis (PVS) is a rare and poorly understood condition that can be classified as primary, acquired, status-post surgical repair of PVS, and/or associated with developmental lung disease. Immunohistochemical studies demonstrate that obstruction of the large (extrapulmonary) pulmonary veins is associated with the neointimal proliferation of myofibroblasts. This rare disorder is likely multifactorial with a spectrum of pathobiology.…
No prominent works on this page.
Progress in Pulmonary Vein Stenosis
Pulmonary vein stenosis (PVS) is a rare and poorly understood condition that can be classified as primary, acquired, status-post surgical repair of PVS, and/or associated with developmental lung disease. Immunohistochemical studies demonstrate that obstruction of the large (extrapulmonary) pulmonary veins is associated with the neointimal proliferation of myofibroblasts. This rare disorder is likely multifactorial with a spectrum of pathobiology.…
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibility, safety, and neuroprotective efficacy of clemastine administration in near-term lambs ( n = 25, 141-143 days) following a global ischemic insult i…
Cardiology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Anesthesia (1 work) · Anesthesia and Neurotoxicity Research (1 work) · Chemistry (1 work) · Congenital Heart Disease Studies (1 work) · Disease (1 work) · Encephalopathy (1 work) · Hypoxia (environmental (1 work)